---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-194111"
form_type: "8-K"
ticker: "RGNX"
cik: "0001590877"
company_name: "REGENXBIO Inc."
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:16:25.175379+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# REGENXBIO grants RSUs to CMO and CSO to promote stability during CEO transition

## Summary
- On August 1, 2024, REGENXBIO granted 58,386 RSUs to EVP/CMO Stephen Pakola and 58,867 RSUs to EVP/CSO Olivier Danos.
- RSUs vest over two years with one-fourth vesting every six months, subject to continued service.
- Grant aims to retain leadership during a period of CEO transition.

## SEC filing metadata
- accession: 0001193125-24-194111
- form_type: 8-K
- ticker: RGNX
- cik: 0001590877
- company_name: REGENXBIO Inc.
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590877/000119312524194111/0001193125-24-194111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590877/000119312524194111/d862743d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-194111
- JSON: https://secwatch.observer/filing/0001193125-24-194111.json
- Plain text: https://secwatch.observer/filing/0001193125-24-194111.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.